PT - JOURNAL ARTICLE AU - Jemielniak, Dariusz AU - Krempovych, Yaroslav TI - # AstraZeneca vaccine disinformation on Twitter AID - 10.1101/2021.04.08.21255107 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.08.21255107 4099 - http://medrxiv.org/content/early/2021/04/16/2021.04.08.21255107.short 4100 - http://medrxiv.org/content/early/2021/04/16/2021.04.08.21255107.full AB - We analyzed 50,080 tweets about # AstraZeneca in English from 2021. We found that the news most common in the frequently retweeted tweets abound in negative information, and in many cases come from media sources well-known for disinformation. Also, we found that RT, a Russian state-sponsored news website, as well as Al Arabiya, a Saudi-owned news website, are frequently retweeted with information about the vaccine. Our analysis identified large coordination networks involved in political astroturfing and vaccine diplomacy in South Asia but also vaccine advocacy networks associated with European Commission employees. Our results show that Twitter discourse about # AstraZeneca is filled with disinformation and bad press, and may be distributed not only organically by anti-vaxxer activists, but also systematically by professional sources.HighlightsMost commonly retweeted media news links abound in negative informationWell established disinformation media sources are retweeted moreState coordinated networks are active in # AstraZeneca astroturfingCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was possible thanks to a grant no. GOSPOSTRATEG-II/0007/2020-00 from Polish National Center for Research and Development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata available upon reasonable request